Last reviewed · How we verify

Citalopram i.v. and p.o

Istituto Auxologico Italiano · Phase 2 active Small molecule

Citalopram i.v. and p.o is a Selective serotonin reuptake inhibitor Small molecule drug developed by Istituto Auxologico Italiano. It is currently in Phase 2 development for Major depressive disorder.

Selective serotonin reuptake inhibitor

Selective serotonin reuptake inhibitor Used for Major depressive disorder.

At a glance

Generic nameCitalopram i.v. and p.o
SponsorIstituto Auxologico Italiano
Drug classSelective serotonin reuptake inhibitor
TargetSerotonin transporter
ModalitySmall molecule
Therapeutic areaNeurology
PhasePhase 2

Mechanism of action

Citalopram acts by inhibiting the reuptake of serotonin in the presynaptic neuron, increasing the amount of serotonin available for binding to postsynaptic receptors.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Citalopram i.v. and p.o

What is Citalopram i.v. and p.o?

Citalopram i.v. and p.o is a Selective serotonin reuptake inhibitor drug developed by Istituto Auxologico Italiano, indicated for Major depressive disorder.

How does Citalopram i.v. and p.o work?

Selective serotonin reuptake inhibitor

What is Citalopram i.v. and p.o used for?

Citalopram i.v. and p.o is indicated for Major depressive disorder.

Who makes Citalopram i.v. and p.o?

Citalopram i.v. and p.o is developed by Istituto Auxologico Italiano (see full Istituto Auxologico Italiano pipeline at /company/istituto-auxologico-italiano).

What drug class is Citalopram i.v. and p.o in?

Citalopram i.v. and p.o belongs to the Selective serotonin reuptake inhibitor class. See all Selective serotonin reuptake inhibitor drugs at /class/selective-serotonin-reuptake-inhibitor.

What development phase is Citalopram i.v. and p.o in?

Citalopram i.v. and p.o is in Phase 2.

What are the side effects of Citalopram i.v. and p.o?

Common side effects of Citalopram i.v. and p.o include Nausea, Diarrhea, Somnolence, Dry mouth, Headache.

What does Citalopram i.v. and p.o target?

Citalopram i.v. and p.o targets Serotonin transporter and is a Selective serotonin reuptake inhibitor.

Related